Clay Siegall
Algemeen Directeur bij IMMUNOME, INC.
Vermogen: 6 M $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Clay Siegall
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.
220
| Non-Profit Organization | Miscellaneous Commercial Services | 220 |
70
| Subsidiary | Pharmaceuticals: Major | 70 |
Washington Roundtable
 Washington Roundtable Miscellaneous Commercial ServicesCommercial Services Washington Roundtable works to affect positive change on public policy issues that are most important to supporting state economic vitality and fostering opportunity. Its work includes sharing news and analysing policy developments. The company was founded in 1983 and is headquartered in Seattle, WA.
56
| Non-Profit Organization | Miscellaneous Commercial Services | 56 |
Washington Biotechnology & Biomedical Association
41
| Non-Profit Organization | 41 | |
| Public Company | Pharmaceuticals: Major | 39 | |
| Subsidiary | Pharmaceuticals: Major | 33 | |
The Pacific Northwest Research Institute, Inc.
 The Pacific Northwest Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Pacific Northwest Research Institute, Inc. is a non-profit organization, which engages in the biomedical research. The interests of the Institute’s investigators range from genetic and genomic studies on the cellular and metabolic processes that lead to cancer and neurological defects to foundational and clinical studies on pancreatic function and diabetes. The company was founded by William Hutchinson in 1956 and is headquartered in Seattle, WA.
22
| Non-Profit Organization | Miscellaneous Commercial Services | 22 |
| Public Company | Biotechnology | 21 | |
| Public Company | Biotechnology | 17 | |
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX.
11
| Extinct | Miscellaneous Commercial Services | 11 |
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million.
10
| Subsidiary | Miscellaneous Commercial Services | 10 |
Bristol-Myers Squibb Pharmaceutical Research Institute
9
| Subsidiary | 9 | |
| Public Company | Pharmaceuticals: Major | 8 | |
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University.
3
| Subsidiary | Biotechnology | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Clay Siegall via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Chairman Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Director of Finance/CFO Chief Executive Officer | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member Chief Executive Officer President | |
| University of Wisconsin | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Chairman Director/Board Member Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal President Chief Tech/Sci/R&D Officer | |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
| The University of Chicago | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| GILEAD SCIENCES, INC. | Biotechnology | Director/Board Member Sales & Marketing Investor Relations Contact | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | President Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor Founder | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Hangzhou Qihan Biotech Co., Ltd.
 Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Medical/Nursing Services | Director/Board Member Chairman | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| Oregon State University | College/University | Undergraduate Degree Doctorate Degree | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman | |
| ZURA BIO LIMITED | Biotechnology | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| SCORPIUS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
United Way of King County
 United Way of King County Miscellaneous Commercial ServicesCommercial Services United Way of King County is a non-profit organization, which provides rental assistance, educational solutions, and financial support. Its programs include Jobs Connect, Streets to Home, Home Base, ParentChild+, Reconnecting Youth, Bridge to Finish, and Free Tax. The company was founded in 1952 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Chairman Chairman | |
American Gas Association
 American Gas Association Miscellaneous Commercial ServicesCommercial Services The American Gas Association represents over 200 energy companies that provide natural gas service to 180 million Americans. The private company is based in Washington. The American company's natural gas utilities are committed to reducing greenhouse gas emissions through new and modernized infrastructure and advanced technologies that maintain reliable, resilient, and affordable energy service choices for consumers. The company advocates on behalf of its member natural gas distribution utilities before Federal agencies in the area of energy market regulation. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| ARCA BIOPHARMA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Undergraduate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Rochester Christian University | College/University | Undergraduate Degree Doctorate Degree | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| MONSANTO | Wholesale Distributors | General Counsel Corporate Officer/Principal | |
| BIOATLA, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 46 |
| Verenigd Koninkrijk | 3 |
| China | 2 |
| Duitsland | 2 |
| Bermuda | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 13 |
| Commercial Services | 9 |
| Health Services | 3 |
| Finance | 2 |
Operationeel
| Director/Board Member | 634 |
| Corporate Officer/Principal | 222 |
| Independent Dir/Board Member | 173 |
| Chairman | 137 |
| Chief Executive Officer | 112 |
Sterkste connecties
| Insiders | |
|---|---|
| Robert More | 42 |
| John Maraganore | 38 |
| George Golumbeski | 36 |
| Ted Love | 31 |
| Steven Holtzman | 28 |
| Felix Baker | 28 |
| David Pyott | 27 |
| Jonathan MacQuitty | 27 |
| James Sapirstein | 26 |
| Daniel Welch | 24 |
| Caley Castelein | 23 |
| Michelle Dipp | 22 |
| Helen Boudreau | 22 |
| Scott Smith | 21 |
| Eran Nadav | 21 |
- Beurs
- Insiders
- Clay Siegall
- Bedrijfsconnecties
